Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cushing’s Disease Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Ketoconazole
1.2.3 Mitotane
1.2.4 Aminoglutethimide
1.2.5 Metyrapone
1.2.6 Mifepristone
1.2.7 Etomidate
1.2.8 Pasireotide
1.3 Market by Application
1.3.1 Global Cushing’s Disease Treatment Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Drug Stores
1.3.5 Clinics
1.3.6 E-Commerce/Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cushing’s Disease Treatment Market Perspective (2018-2033)
2.2 Cushing’s Disease Treatment Growth Trends by Region
2.2.1 Global Cushing’s Disease Treatment Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Cushing’s Disease Treatment Historic Market Size by Region (2018-2023)
2.2.3 Cushing’s Disease Treatment Forecasted Market Size by Region (2024-2033)
2.3 Cushing’s Disease Treatment Market Dynamics
2.3.1 Cushing’s Disease Treatment Industry Trends
2.3.2 Cushing’s Disease Treatment Market Drivers
2.3.3 Cushing’s Disease Treatment Market Challenges
2.3.4 Cushing’s Disease Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cushing’s Disease Treatment Players by Revenue
3.1.1 Global Top Cushing’s Disease Treatment Players by Revenue (2018-2023)
3.1.2 Global Cushing’s Disease Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Cushing’s Disease Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cushing’s Disease Treatment Revenue
3.4 Global Cushing’s Disease Treatment Market Concentration Ratio
3.4.1 Global Cushing’s Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cushing’s Disease Treatment Revenue in 2022
3.5 Cushing’s Disease Treatment Key Players Head office and Area Served
3.6 Key Players Cushing’s Disease Treatment Product Solution and Service
3.7 Date of Enter into Cushing’s Disease Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cushing’s Disease Treatment Breakdown Data by Type
4.1 Global Cushing’s Disease Treatment Historic Market Size by Type (2018-2023)
4.2 Global Cushing’s Disease Treatment Forecasted Market Size by Type (2024-2033)
5 Cushing’s Disease Treatment Breakdown Data by Application
5.1 Global Cushing’s Disease Treatment Historic Market Size by Application (2018-2023)
5.2 Global Cushing’s Disease Treatment Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Cushing’s Disease Treatment Market Size (2018-2033)
6.2 North America Cushing’s Disease Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Cushing’s Disease Treatment Market Size by Country (2018-2023)
6.4 North America Cushing’s Disease Treatment Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cushing’s Disease Treatment Market Size (2018-2033)
7.2 Europe Cushing’s Disease Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Cushing’s Disease Treatment Market Size by Country (2018-2023)
7.4 Europe Cushing’s Disease Treatment Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cushing’s Disease Treatment Market Size (2018-2033)
8.2 Asia-Pacific Cushing’s Disease Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Cushing’s Disease Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Cushing’s Disease Treatment Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cushing’s Disease Treatment Market Size (2018-2033)
9.2 Latin America Cushing’s Disease Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Cushing’s Disease Treatment Market Size by Country (2018-2023)
9.4 Latin America Cushing’s Disease Treatment Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cushing’s Disease Treatment Market Size (2018-2033)
10.2 Middle East & Africa Cushing’s Disease Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Cushing’s Disease Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Cushing’s Disease Treatment Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 CORCEPT THERAPEUTICS
11.1.1 CORCEPT THERAPEUTICS Company Detail
11.1.2 CORCEPT THERAPEUTICS Business Overview
11.1.3 CORCEPT THERAPEUTICS Cushing’s Disease Treatment Introduction
11.1.4 CORCEPT THERAPEUTICS Revenue in Cushing’s Disease Treatment Business (2018-2023)
11.1.5 CORCEPT THERAPEUTICS Recent Development
11.2 HRA Pharma
11.2.1 HRA Pharma Company Detail
11.2.2 HRA Pharma Business Overview
11.2.3 HRA Pharma Cushing’s Disease Treatment Introduction
11.2.4 HRA Pharma Revenue in Cushing’s Disease Treatment Business (2018-2023)
11.2.5 HRA Pharma Recent Development
11.3 Strongbridge Biopharma
11.3.1 Strongbridge Biopharma Company Detail
11.3.2 Strongbridge Biopharma Business Overview
11.3.3 Strongbridge Biopharma Cushing’s Disease Treatment Introduction
11.3.4 Strongbridge Biopharma Revenue in Cushing’s Disease Treatment Business (2018-2023)
11.3.5 Strongbridge Biopharma Recent Development
11.4 Novartis
11.4.1 Novartis Company Detail
11.4.2 Novartis Business Overview
11.4.3 Novartis Cushing’s Disease Treatment Introduction
11.4.4 Novartis Revenue in Cushing’s Disease Treatment Business (2018-2023)
11.4.5 Novartis Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Cushing’s Disease Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Ketoconazole
Table 3. Key Players of Mitotane
Table 4. Key Players of Aminoglutethimide
Table 5. Key Players of Metyrapone
Table 6. Key Players of Mifepristone
Table 7. Key Players of Etomidate
Table 8. Key Players of Pasireotide
Table 9. Global Cushing’s Disease Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 10. Global Cushing’s Disease Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 11. Global Cushing’s Disease Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 12. Global Cushing’s Disease Treatment Market Share by Region (2018-2023)
Table 13. Global Cushing’s Disease Treatment Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 14. Global Cushing’s Disease Treatment Market Share by Region (2024-2033)
Table 15. Cushing’s Disease Treatment Market Trends
Table 16. Cushing’s Disease Treatment Market Drivers
Table 17. Cushing’s Disease Treatment Market Challenges
Table 18. Cushing’s Disease Treatment Market Restraints
Table 19. Global Cushing’s Disease Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 20. Global Cushing’s Disease Treatment Market Share by Players (2018-2023)
Table 21. Global Top Cushing’s Disease Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cushing’s Disease Treatment as of 2022)
Table 22. Ranking of Global Top Cushing’s Disease Treatment Companies by Revenue (US$ Million) in 2022
Table 23. Global 5 Largest Players Market Share by Cushing’s Disease Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Cushing’s Disease Treatment Product Solution and Service
Table 26. Date of Enter into Cushing’s Disease Treatment Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Cushing’s Disease Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 29. Global Cushing’s Disease Treatment Revenue Market Share by Type (2018-2023)
Table 30. Global Cushing’s Disease Treatment Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 31. Global Cushing’s Disease Treatment Revenue Market Share by Type (2024-2033)
Table 32. Global Cushing’s Disease Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 33. Global Cushing’s Disease Treatment Revenue Market Share by Application (2018-2023)
Table 34. Global Cushing’s Disease Treatment Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 35. Global Cushing’s Disease Treatment Revenue Market Share by Application (2024-2033)
Table 36. North America Cushing’s Disease Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. North America Cushing’s Disease Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 38. North America Cushing’s Disease Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 39. Europe Cushing’s Disease Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 40. Europe Cushing’s Disease Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 41. Europe Cushing’s Disease Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 42. Asia-Pacific Cushing’s Disease Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 43. Asia-Pacific Cushing’s Disease Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 44. Asia-Pacific Cushing’s Disease Treatment Market Size by Region (2024-2033) & (US$ Million)
Table 45. Latin America Cushing’s Disease Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Latin America Cushing’s Disease Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 47. Latin America Cushing’s Disease Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 48. Middle East & Africa Cushing’s Disease Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 49. Middle East & Africa Cushing’s Disease Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 50. Middle East & Africa Cushing’s Disease Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 51. CORCEPT THERAPEUTICS Company Detail
Table 52. CORCEPT THERAPEUTICS Business Overview
Table 53. CORCEPT THERAPEUTICS Cushing’s Disease Treatment Product
Table 54. CORCEPT THERAPEUTICS Revenue in Cushing’s Disease Treatment Business (2018-2023) & (US$ Million)
Table 55. CORCEPT THERAPEUTICS Recent Development
Table 56. HRA Pharma Company Detail
Table 57. HRA Pharma Business Overview
Table 58. HRA Pharma Cushing’s Disease Treatment Product
Table 59. HRA Pharma Revenue in Cushing’s Disease Treatment Business (2018-2023) & (US$ Million)
Table 60. HRA Pharma Recent Development
Table 61. Strongbridge Biopharma Company Detail
Table 62. Strongbridge Biopharma Business Overview
Table 63. Strongbridge Biopharma Cushing’s Disease Treatment Product
Table 64. Strongbridge Biopharma Revenue in Cushing’s Disease Treatment Business (2018-2023) & (US$ Million)
Table 65. Strongbridge Biopharma Recent Development
Table 66. Novartis Company Detail
Table 67. Novartis Business Overview
Table 68. Novartis Cushing’s Disease Treatment Product
Table 69. Novartis Revenue in Cushing’s Disease Treatment Business (2018-2023) & (US$ Million)
Table 70. Novartis Recent Development
Table 71. Research Programs/Design for This Report
Table 72. Key Data Information from Secondary Sources
Table 73. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cushing’s Disease Treatment Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Cushing’s Disease Treatment Market Share by Type: 2022 VS 2033
Figure 3. Ketoconazole Features
Figure 4. Mitotane Features
Figure 5. Aminoglutethimide Features
Figure 6. Metyrapone Features
Figure 7. Mifepristone Features
Figure 8. Etomidate Features
Figure 9. Pasireotide Features
Figure 10. Global Cushing’s Disease Treatment Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 11. Global Cushing’s Disease Treatment Market Share by Application: 2022 VS 2033
Figure 12. Hospital Pharmacies Case Studies
Figure 13. Retail Pharmacies Case Studies
Figure 14. Drug Stores Case Studies
Figure 15. Clinics Case Studies
Figure 16. E-Commerce/Online Pharmacies Case Studies
Figure 17. Cushing’s Disease Treatment Report Years Considered
Figure 18. Global Cushing’s Disease Treatment Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 19. Global Cushing’s Disease Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 20. Global Cushing’s Disease Treatment Market Share by Region: 2022 VS 2033
Figure 21. Global Cushing’s Disease Treatment Market Share by Players in 2022
Figure 22. Global Top Cushing’s Disease Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cushing’s Disease Treatment as of 2022)
Figure 23. The Top 10 and 5 Players Market Share by Cushing’s Disease Treatment Revenue in 2022
Figure 24. North America Cushing’s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. North America Cushing’s Disease Treatment Market Share by Country (2018-2033)
Figure 26. United States Cushing’s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Canada Cushing’s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Europe Cushing’s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Europe Cushing’s Disease Treatment Market Share by Country (2018-2033)
Figure 30. Germany Cushing’s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. France Cushing’s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. U.K. Cushing’s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Italy Cushing’s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Russia Cushing’s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Nordic Countries Cushing’s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Asia-Pacific Cushing’s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Asia-Pacific Cushing’s Disease Treatment Market Share by Region (2018-2033)
Figure 38. China Cushing’s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Japan Cushing’s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. South Korea Cushing’s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Southeast Asia Cushing’s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. India Cushing’s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Australia Cushing’s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Latin America Cushing’s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Latin America Cushing’s Disease Treatment Market Share by Country (2018-2033)
Figure 46. Mexico Cushing’s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Brazil Cushing’s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Middle East & Africa Cushing’s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Middle East & Africa Cushing’s Disease Treatment Market Share by Country (2018-2033)
Figure 50. Turkey Cushing’s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 51. Saudi Arabia Cushing’s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 52. CORCEPT THERAPEUTICS Revenue Growth Rate in Cushing’s Disease Treatment Business (2018-2023)
Figure 53. HRA Pharma Revenue Growth Rate in Cushing’s Disease Treatment Business (2018-2023)
Figure 54. Strongbridge Biopharma Revenue Growth Rate in Cushing’s Disease Treatment Business (2018-2023)
Figure 55. Novartis Revenue Growth Rate in Cushing’s Disease Treatment Business (2018-2023)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed